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Abstract—Objective: Treatment planning is a time-consuming, 
iterative process with potentially high inter-planner variability. 
Fully automated treatment planning processes could reduce a 
planner’s active treatment planning time and remove inter-
planner variability, with the potential to tremendously improve 
patient turnover and quality of care.  In developing fully 
automated algorithms for treatment planning, we have two main 
objectives: to produce plans that are 1) pareto optimal and 2) 
clinically acceptable. Here, we propose the pareto optimal 
projection search (POPS) algorithm, which provides a general 
framework for directly searching the pareto front. Methods: Our 
POPS algorithm is a novel automated planning method that 
combines two main search processes: 1) gradient-free search in the 
decision variable space and 2) projection of decision variables to 
the pareto front using the bisection method. We demonstrate the 
performance of POPS by comparing with clinical treatment plans. 
As one possible quantitative measure of treatment plan quality, we 
adopt a clinical acceptability scoring function (SF) modified from 
the previously developed general evaluation metric (GEM). 
Results: On a dataset of 21 prostate IMRT cases collected at the 
Stanford Radiation Oncology Clinic (SROC), our proposed POPS 
algorithm produces pareto optimal plans that perform well in 
regards to clinical acceptability. Compared to the SF scores of 
manually generated plans, SF scores for POPS plans were 
significantly better (𝒑 = 𝟐. 𝟔 × 𝟏𝟎ି𝟕). Conclusion: Our proposed 
POPS algorithm provides a general framework for fully 
automated treatment planning that achieves clinically acceptable 
dosimetric quality without requiring active planning from human 
planners. Significance: Our fully automated POPS algorithm 
addresses many key limitations of other automated planning 
approaches, and we anticipate that it will substantially improve 
treatment planning workflow.  
 
Index Terms— Automated treatment planning, POPS, Pareto 
optimal, Plan Optimization 
 
I. INTRODUCTION 
XTERNAL beam radiation therapy involves the 
delivery of ionizing radiation with the intent to treat 
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diseased tissue while minimizing dose to healthy organs [1], 
[2]. The goal of treatment planning is then to determine optimal 
beam angles, shapes, intensities, etc. that satisfy this overall 
clinical objective.  
Prior to treatment, medical images are collected for the 
patient (e.g. CT, MRI, or PET scans), and physicians contour 
various anatomical structures on the collected images, 
including the planning target volume (PTV) and surrounding 
organs-at-risk (OARs) [3], [4]. For the case of intensity 
modulated radiation therapy (IMRT), planners determine the 
appropriate plan configuration (i.e. beam type, beam angle 
arrangement, etc.) and perform inverse planning to achieve a 
desired dose distribution or to satisfy various objectives and 
constraints [3], [4]. 
Traditionally, treatment planning has been regarded as a 
manual, iterative process to be performed by human planners. 
In this process, planners repeatedly adjust treatment planning 
parameters (TPPs), such as objective weights, dose constraint 
values, etc., until a clinically acceptable treatment plan solution 
is found. The iterative planning process is often conceptualized 
as a two-loop optimization process [5]. This iterative planning 
process is not only time-consuming and labour intensive, but 
the resulting plan quality highly depends on planner skill and 
experience [6]–[12], [5]. 
In developing automated methods for treatment planning, 
two main considerations are to produce plans that are pareto 
optimal and clinically acceptable. We also point out the 
distinction between automated methods (i.e. methods that 
reduce active planning from a human planner) and fully 
automated methods (i.e. methods requiring no active planning 
from a human planner). Pareto optimal plans are efficient—that 
is we cannot improve one aspect (e.g., reduce the dose in one 
OAR) without compromising at least one other aspect (e.g., 
reduce the PTV dose)[13], [14]. Plans that are not pareto 
optimal (i.e. dominated plans) are inefficient, and there exists a 
more optimal plan that, for instance, achieves better organ 
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sparing for all OARs. Intuitively, producing efficient plans is a 
cornerstone of high-quality patient care, but not all pareto 
optimal plans are acceptable clinically. It is, therefore, critically 
important to produce plans that both efficient and clinically 
acceptable.  
A. Related Works 
Here, we provide a summary of various automated treatment 
planning approaches and point to a more in-depth review[15] 
for interested readers. Limitations with iterative treatment 
planning have spurred great interest in automated approaches, 
which can generally be categorized as knowledge-based 
planning (KBP) [16]–[19], protocol-based planning (PBP)[7], 
[8], [20]–[23], and multicriteria optimization (MCO) [6], [13], 
[24]–[27]. As each category of approach has its own benefits 
and drawbacks, no clear consensus has been reached on an 
approach that can replace manual planning, and, in practice, a 
combination of various approaches may be used in a case-by-
case fashion. 
KBP methods are a category of methods based on the 
premise that treatment planning results can be predicted from 
the geometric and anatomical information of a patient [16]. 
KBP typically follows the paradigm of training a supervised 
machine learning model on a dataset of previously generated 
treatment plans. Given input information in the form of a 
patient’s CT and structure segmentations, a knowledge-based 
model attempts to predict voxel-wise dose or the dose-volume 
histogram (DVH) [16]–[19]. Previous works report that 
knowledge-based models can accurately predict treatment 
planning results [16]–[18], but these results are often limited to 
a subset of  the information in treatment plans (i.e. dose 
distribution, DVH, etc.) and are not equivalent to performing 
the treatment planning process. In cases where KBP performs 
poorly, lack of model interpretability limits the usability of 
KBP approaches. Moreover, because KBP is typically 
formulated as a supervised learning problem, it also does not 
guarantee that pareto optimal plans are produced and, instead, 
only attempts to produce plans that are similar to the ground-
truth data used in training. Moreover, due to the potential 
overfitting of these trained models and their lack of 
interpretability (i.e. being regarded as black-box models due to 
complexity of model architectures), their practical usability in 
the clinic is currently limited. 
PBP methods are a category of methods that employ rules or 
heuristics to mimic an experienced treatment planner 
performing iterative planning. Previous works have proposed 
various rules for adjusting treatment planning parameters (i.e. 
objective weights, constraint values, etc.) based on advice from 
consulted physicians [8], [20]–[23]. Others have followed a 
model-free approach, opting to use reinforcement learning to 
mimic human planners [7].  
While protocol-based methods may offer a practical 
approach to automation, there are two main limitations that 
have yet to be addressed. First, the design of rules or heuristics 
for protocol-based planning highly depends on the perspective 
of the planner, leading to variable plan quality between 
institutions or even individual planners[8], [9]. Automated 
approaches, ideally, should remove inter-planner variability 
and provide a baseline method for producing high-quality 
treatment plans, but the issue of inter-planner variability 
remains very present in protocol-based approaches. Second, 
just as knowledge-based planning does not necessarily produce 
pareto optimal plans, protocol-based planning does not either.  
Unlike KBP and PBP approaches, MCO approaches attempt 
to generate pareto optimal treatment plans. That is, treatment 
plans in which we cannot improve one aspect (e.g., reduce the 
dose in one OAR) without compromising at least one other 
aspect (e.g., reduce the PTV dose). Multicriteria optimization 
approaches can be further divided into a posteriori MCO [13], 
[24], [25] and a priori MCO [6], [26], [27]. 
In a priori MCO, a pareto optimal solution is found 
according to provided preferences. Such approaches require 
sufficient preference information to be provided by the planner, 
and some notable examples include scalarization (e.g. ϵ - 
constraint method, achievement scalarization, etc.) [28], 
prioritized optimization [6], [26], [27], and the lexicographic 
method [29]. Translating physicians’ intuitions regarding ideal 
planning to a list of preferences, however, is no trivial task, and 
sometimes treatment plan solutions found from preference 
information may not align with a planner’s expectations. Where 
 
Figure 1. (a) Visualization of the separate decision variable and objective function spaces for weighted optimization problem 
setups. (b) Visualization for the direct projections between the decision variable space and the pareto front for POPS 
preference information may only capture general trends 
observed by a physician, more nuanced metrics that utilize 
dose-volume histogram information is likely necessary. 
A posteriori MCO, by contrast, explicitly place the decision 
of selecting treatment plans in the hands of the planner. These 
methods attempt to generate or approximate the pareto surface, 
creating a database of pareto optimal treatment plans that a 
physician might choose from. Previous works have proposed 
alternative ways to generate the pareto surface (e.g. Pareto 
surface generation for convex multi-objective instances or 
PGEN, simulated annealing, evolutionary algorithms, etc.) or at 
least approximate its shape assuming a convex formulation to 
the problem [13], [24], [25]. A posteriori methods, in general, 
produce pareto optimal and clinically acceptable plans, though 
at high computational cost. Further, these methods still require 
physicians to select clinically acceptable plans from the 
generated database and, therefore, are not fully automated 
methods. 
Our fully automated pareto optimal projection search 
(POPS) algorithm directly searches the pareto front for 
clinically acceptable plans, doing so in a fully automatic 
fashion. Like previous MCO approaches, POPS produces 
pareto optimal plans, ideally, without the limitations of a priori 
and a posteriori methods. Instead of a list of preferences based 
on general trends, POPS uses a detailed scoring function to 
evaluate plans on clinical acceptability. POPS additionally 
performs an automated search using such a scoring function, 
and, in theory, does not require any active planning from human 
planners as is necessary for a posteriori methods. Our results 
demonstrate that POPS indeed produces pareto optimal 
treatment plans that perform at least as well as dosimetrist 
generated plans in terms of clinical acceptability. 
II. METHODS 
A. Problem Formulation 
The purpose of our fully automated POPS algorithm is two-
fold: to produce treatment plans that are both pareto optimal and 
optimal with respect to clinical acceptability. Alternative 
automated approaches like KBP and PBP have a key limitation 
in that they do not necessarily generate pareto optimal plans. 
Moreover, alternative MCO approaches discuss methods for 
generating the pareto front while delegating the task of selecting 
the acceptable plan to a human planner. Our approach provides 
a practical way to search the pareto front for clinically 
acceptable plans, producing plans that are both pareto optimal 
and clinically acceptable. 
As previously mentioned, pareto optimal plans are non-
dominated and further improvements to the plan in regards to 
one aspect are only made by trading-off in regards to other 
aspects. Intuitively, pareto optimal treatment plans lie on the 
front between the region of feasible and infeasible plans. As 
described previously, one valid way of formulating the problem 
is to perform multicriteria optimization with multiple weighted 
objective functions. Such an approach, however, involves a 
separate decision space and objective function space (as 
depicted in Figure 1a). Our proposed POPS algorithm instead 
formulates the iterative treatment planning problem as a 
feasibility search, which allows for a more direct relationship 
between the decision and constraint feasibility spaces (Figure 
1b). We can then project points from the decision space to the 
constraint feasibility space and utilize any gradient-free 
searching algorithm to navigate to our desired treatment plan 
solution. 
 
B. Quantifying Clinical Acceptability 
By convention, the evaluation of treatment plans has been a 
manual, iterative, and qualitative process. In performing their 
qualitative evaluation, physicians ideally draw on their 
repository of clinical experience to judge various components 
of the plan. Previous works that explore various DVH 
constraints have attempted to operationalize the considerations 
made in a physician’s qualitative assessment [12], [30], [31]. 
Similarly, evaluation of treatment plans through various metrics 
Table 1. List of clinical acceptability criteria used in scoring prostate IMRT patients, the priority of each OAR, and the alpha 
values for the piece-wise sigmoid function. 
 
 Clinical Acceptability Criteria Priority 𝛼ଵ 𝛼ଶ 
Rectum 𝐷(80%)≤ 30 
𝐷(55%)
≤ 47 
𝐷(40%)
≤ 65 
𝐷(25%)
≤ 70 
𝐷(10%)
≤ 75 2 0.2 3 
Bladder 𝐷(80%) ≤ 30 𝐷(55%) ≤ 47 𝐷(30%) ≤ 70 3 0.2 3 
Right 
Femoral 
Head 
𝐷(𝑚𝑎𝑥) ≤ 50 4 0.2 3 
Left 
Femoral 
Head 
𝐷(𝑚𝑎𝑥) ≤ 50 4 0.2 3 
Body 𝐷(15%)≤ 12 𝐷(3%) ≤ 47 
𝐷(1.5%)
≤ 70 
𝐷(𝑚𝑎𝑥)
≤ 82 5 0.2 3 
 
has been used previously in knowledge based planning [16]–
[18], as well as more broadly for data analytics [12], [30], [31].  
 To summarize the general intuition that can be followed in 
quantifying clinical acceptability of treatment plans, the overall 
quality of a treatment plan can be determined by assessing its 
performance in regards to individual metrics and criteria. We 
can first define a list of criteria, termed clinical acceptability 
criteria, that a physician might incorporate into their evaluation. 
As a foundation for our proposed list, we incorporate criteria 
from the list of DVH constraints discussed in Chen et al.[32]. 
While this particular list of criteria may not be agreeable to 
every physician, the entries can be readily changed to suit 
individual preferences or to follow various institutional 
protocol. Essentially each criteria represents a chosen control 
point on the DVH, and while we use the control points 
identified in Chen et al., other control points may certainly be 
used to similar effect. The main heuristic we follow in selecting 
these criteria is to provide relatively uniform sampling to the 
DVH for each organ. Based on advice from consulted 
physicians and our uniform sampling heuristic, we then 
incorporate additional criteria to judge sparing of the body, 
separate from sparing of surrounding OARs. The full list of 
criteria is included in Table 1. 
 From a list of criteria, we can then design individual scoring 
functions ideally tailored to the criteria and structure being 
judged. Previous works have proposed a variety of scoring 
functions [12], [30], [31]. While some of these scoring 
functions (e.g. step function, regret, etc.) are too broad and lack 
organ-specific considerations [12], [31], other scoring functions 
incorporate organ-specific considerations implicitly through 
the use of statistics that require a long history of treatment plan 
solutions [30]. 
 Our adopted SF score, instead, attempts to incorporate 
interpretable, organ-specific scoring from literature [30] 
without requiring a lengthy history of treatment plan solutions. 
To that end, we modify the previously proposed generalized 
evaluation metric (GEM) score, replacing its gamma 
distribution probability term with piece-wise sigmoid 
functions. 
 As shown in Equation 1 and 2, the intuition of organ-
specific scoring is encapsulated by tailored piece-wise sigmoid 
functions (where αଵ and αଶ describe the steepness of the 
sigmoid functions and are chosen empirically) and a priority-
based weighting (where the weighting scheme is adapted from 
Mayo et al. [30]). To select the steepness of the sigmoid 
functions, we adhere to the following heuristics: 
1. Decreasing DVH values for each organ imply better 
sparing to that organ 
2. Organ doses approaching 0 have diminishing 
returns, in regards to score 
3.  Not satisfying the listed clinical acceptability 
criteria is highly undesirable and intuitively results 
in a bad score 
Following these heuristics, 𝛼ଵ is selected to be small in order to 
abide by heuristic 2 and 𝛼ଶ is selected to be large relative to 𝛼ଵ 
in order to abide by heuristic 3. Priority values for each OAR 
were selected based on advice from consulted physicians.  
Following the precedent of Mayo et al.[30], our clinical 
acceptability criteria do not include the target volume. For 
prostate IMRT, where the target volume is relatively large and 
the dose distribution to the target is relatively homogeneous (at 
least for the dose constraints used here), inclusion of target 
volume clinical acceptability criteria may be unnecessary. For 
other regions of the body or in particularly complex treatment  
 planning cases, target volume criteria can certainly be 
incorporated without affecting POPS performance. 
In Equation 2, 𝑠 refers to a structure (OAR) in the structure 
set 𝑆. The priority of a specific structure, 𝑃𝑟𝑖𝑜𝑟𝑖𝑡𝑦௦, adjusts its 
exponential weighting. 𝑖 refers to a clinical acceptability criteria 
(as listed in Table 1), 𝑁௦ refers to the total number of clinical 
acceptability criteria for a specific structure, and 𝜎± refers to 
the structure score computed using a piecewise sigmoid 
function of the difference between the plan value 𝑃𝑉௜  and the 
criteria value 𝐶𝑉௜. 
 As an example, to compute the structure score for the second 
bladder criteria (𝐷(55%) ≤ 47), we first compute the 
difference 𝑧௜  =  𝑃𝑉௜ − 𝐶𝑉௜ . Here, 𝐶𝑉௜ = 47 𝐺𝑦 and 𝑃𝑉௜  is 
found as the corresponding dose on the bladder DVH for 55%  
 volume. In this toy example, we use a plan value 𝑃𝑉௜ = 20 𝐺𝑦, 
αଵ = 0.2, and αଶ = 3. We would then compute the structure 
score 𝜎௜±(𝑧௜ , 𝛼ଵ, 𝛼ଶ)  = 0.0045. Assuming the solution is 
feasible, the scoring function then performs a weighted-average 
using OAR priorities. Our results use the priorities as listed in 
Table 1, which were determined based on advice from 
consulted physicians, but they may also be changed to better 
suit individual planner preferences. 
Intuitively, our proposed SF scores treatment plans on a scale 
between 0 and 1, where lower scores are better. Plans that attain 
scores of 0.5 satisfy the listed clinical acceptability criteria, on 
 
𝑆𝐹 = ൞
1,   if solution is infeasible
∑ 2ି௉௥௜௢௥௜௧௬ೞାଵ ⋅ ∑ 𝜎௜
±(𝑃𝑉௜ − 𝐶𝑉௜, 𝛼ଵ, 𝛼ଶ)௜ ∈ ௦
𝑁௦௦ ∈ ௌ
∑ 2ି௉௥௜௢௥௜௧௬ೞାଵ௦ ∈ ௌ
, 𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒
 
(1) 
𝜎௜±(𝑧௜, 𝛼ଵ, 𝛼ଶ)  =  ൞
1
1 + 𝑒ିఈభ௭
, 𝑧 ≤ 0
1
1 + 𝑒ିఈమ௭
, 𝑧 > 0
 (2) 
average. Plans that attain scores smaller than 0.5 achieve better 
OAR sparing, on average, than a plan that just satisfies the listed 
clinical acceptability criteria.  
 
C.  POPS Algorithm 
 The general methodology of our proposed POPS algorithm 
combines two search methodologies: 1) a projection from the 
decision variable space to the pareto front using the bisection 
method and 2) a gradient-free search (i.e. simplex search) of the 
decision variable space—and the corresponding points on the 
pareto front—for a clinically acceptable treatment plan. Our 
implementation utilizes Nelder-Mead simplex search due to its 
simplicity, but our methods can incorporate any gradient-free 
optimization approach. To allow for better reproducibility of 
our results, we implement our approach using the open-source 
MatRad software package.  
 To start, we define the coordinates of a point 𝑝 in the 
decision variable space as (𝑐ଵ, 𝑐ଶ, … , 𝑐௡) (i.e. red circles in 
Figure 2), the coordinates of a projected point 𝑝ᇱ on the pareto 
front as (𝑐′ଵ, 𝑐′ଶ, … , 𝑐′௡) (i.e. blue circles in Figure 2), and the 
SF score of the projected point as 𝑓(𝑝ᇱ). We can then formulate 
the iterative treatment planning problem as a feasibility search 
using Equation 3. We note that POPS performs equally well if 
other constraints are chosen besides equivalent uniform dose 
(EUD) (i.e. mean, max, and DVH constraints). 
 For clarity, we provide visualizations for a hypothetical 2D 
case below (see Figures 2 and 3 for visualizations of the pareto 
front in 2D). However, our POPS algorithm generalizes to n-
dimensional cases, and results are provided in later sections for 
5D prostate IMRT cases. 
 
POPS: 
1.  Define the bounds 𝑝௕,ଵ, 𝑝௕,ଶ, . . . , 𝑝௕,௡ for the decision 
variable search space by projecting a seed point 𝑝௦ onto 
the pareto front.  
Projection of the seed point can be performed using a variety 
of methods. In our implementation, we perform projections by 
conducting a one-dimensional search using the bisection 
method along a vector direction. When projecting the seed point 
to define the decision space bounds, we perform the one-
dimensional search by tightening the EUD constraint in one 
OAR (while fixing all other constraints), and repeat this 
projection for each OAR (five times total for a 5D prostate 
case). The projected points will form the bounds for the 
decision space and can be visualized as a simplex (see Figure 
2b). 
As visualizations for n-D are too difficult, we instead provide 
visualizations in 2D where the feasibility search space is in 𝑅𝟚 
while the decision space is the line bounded by the initial 
projected points. For a n-dimension treatment planning 
𝑚𝑖𝑛
௫
 1
𝑁௣௧௩
෍ ൫𝑑௝ − 𝑑መ൯
ଶ
௝ ∈ ௣௧௩
 
 
𝑠. 𝑡. 𝑥 ≥ 0 
𝑐ா௎஽,௥௘௖௧௨௠ ≤ 𝑐ଵ 
𝑐ா௎஽,௕௟௔ௗௗ௘௥ ≤ 𝑐ଶ 
𝑐ா௎஽,ிு ோ ≤ 𝑐ଷ 
𝑐ா௎஽,ிு ௅ ≤ 𝑐ସ 
𝑐ா௎஽,௕௢ௗ௬ ≤ 𝑐ହ 
𝐷௣௧௩(95%) ≥ 76 
𝐷௣௧௩(𝑚𝑖𝑛) = 74 
𝐷௣௧௩(𝑚𝑎𝑥) = 82 
 
  (3) 
 
Figure 2. (a) Visualization of the POPS algorithm for a hypothetical 2D problem. (b) Starting from a seed point, we define the 
bounds for the decision variable space by projecting the seed point using the bisection method. (c) We then define the initial 
simplex and (d) project the initial simplex to the pareto front, while computing the SF score for each projected point. (e) We can 
then use a gradient-free search (i.e. simplex search) to search the pareto front for a clinically acceptable treatment plan. 
problem, the constraint feasibility search space is in 𝑅௡ while 
the decision space is a simplex bounded by 𝑛 points that are 
found by projecting the seed point along orthogonal directions. 
2. Within the bounded decision space, define the initial 
simplex vertices 𝑝ଵ , 𝑝ଶ, . . . , 𝑝௡. 
For simplicity, we define our initial vertices by taking the 
weighted average of the boundary points.  
 𝜏௜,௝  =   ൜
0.3, 𝑖𝑓 𝑖 =  𝑗
1, 𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒 (4) 
 𝑝௜  =  
∑ 𝑝௕,௜𝜏௜,௝௡௝ୀଵ
∑ 𝜏௜,௝௡௝ୀଵ
 (5) 
Here, 𝜏௜,௝ refers to the weights assigned to each boundary 
point 𝑝௕,௜. Prior knowledge can also be incorporated in the form 
of better starting simplex vertices, but our implementation uses 
a more straightforward initialization for reproducibility. 
3. Project each of the simplex vertices 𝑝ଵ, 𝑝ଶ, . . . , 𝑝௡ from the 
decision space to the pareto front to obtain the projected 
points 𝑝′ଵ, 𝑝′ଶ, . . . , 𝑝′௡ , again using the bisection method. 
Here we describe the projection component that is an 
important recurring theme in the POPS algorithm. Projection of 
the simplex vertices to the pareto front is visualized for the 2D 
case in Figure 2d. In contrast to the projection of the seed point, 
all subsequent projections use the bisection method to perform 
a one-dimensional search along a fixed vector direction. To 
determine this vector direction, we empirically calculate the 
vector from the centroid of the initial simplex to the origin. 
Example visualizations for one-dimensional search along this 
vector direction are shown as solid black lines in Figure 2.  
4. Compute the function evaluation (i.e. SF score) for each of 
the projected simplex vertices to obtain 
𝑓(𝑝ଵᇱ ), 𝑓(𝑝ଶᇱ ), . . . , 𝑓(𝑝௡ᇱ ). 
We can compute the SF score for a particular treatment plan 
solution 𝑝 using Equations 1 and 2. 
5. Order the simplex points by their function evaluations such 
that 𝑓(𝑝ଵᇱ ) ≤ 𝑓(𝑝ଶᇱ ) ≤ . . .  ≤ 𝑓(𝑝௡ᇱ ) 
6. Compute the centroid 𝑝௖ of the 𝑛 − 1 best simplex points  
7. Reflection: 
a. Compute the reflected point in the decision space 
as 𝑝௥ = 𝑝௖ + α(𝑝௖ − 𝑝௡). We follow the official 
MATLAB version and use α =  1.  
b. Project the reflected point to the pareto front to 
obtain 𝑝௥ᇱ .  
c. Compute the function evaluation 𝑓(𝑝௥ᇱ ). 
d. If 𝑓(𝑝′ଵ) ≤ 𝑓(𝑝௥ᇱ ) < 𝑓(𝑝′௡ିଵ), replace the worst 
simplex point with 𝑝௥ and start from 5. 
8. Expansion: 
a. If 𝑓(𝑝௥ᇱ ) < 𝑓(𝑝′ଵ), compute the expansion point 
in the decision space as 𝑝௘ = 𝑝௖ + β(𝑝௖ − 𝑝௡). 
We follow the official MATLAB version and use 
β =  1. 
b. Project the expansion point to the pareto front to 
obtain 𝑝௘ᇱ .  
c. Compute the function evaluation 𝑓(𝑝௘ᇱ ). 
d. If 𝑓(𝑝௘ᇱ ) < 𝑓(𝑝′௥), replace the worst simplex 
point with 𝑝௘ and start from 5. 
e. Otherwise, replace the worst simplex point with 
𝑝௥ and start from 5. 
9. Outside Contraction: 
a. If 𝑓൫𝑝ᇱ௡ିଵ൯ ≤ 𝑓(𝑝௥
ᇱ ) < 𝑓൫𝑝ᇱ௡൯, compute the 
outside contraction point in the decision space as 
𝑝௢௖ = 𝑝௖ + γ(𝑝௥ − 𝑝௖). We follow the official 
MATLAB version and use γ =  0.5. 
b. Project the outside contraction point to the pareto 
front to obtain 𝑝௢௖ᇱ .  
c. Compute the function evaluation 𝑓(𝑝௢௖ᇱ ). 
d. If 𝑓(𝑝௢௖ᇱ ) < 𝑓(𝑝′௥), replace the worst simplex 
point with 𝑝௢௖ and start from 5. 
e. Otherwise, continue to step 11  
10. Inside Contraction: 
a. If 𝑓൫𝑝ᇱ௡൯ ≤ 𝑓(𝑝௥
ᇱ ), compute the inside 
contraction point in the decision space as 𝑝௜௖ =
𝑝௖ + γ(𝑝௡ − 𝑝௖). We follow the official 
MATLAB version and use γ =  0.5. 
b. Project the inside contraction point to the pareto 
front to obtain 𝑝௜௖ᇱ .  
c. Compute the function evaluation 𝑓(𝑝௜௖ᇱ ). 
d. If 𝑓(𝑝௜௖ᇱ ) < 𝑓(𝑝′௡), replace the worst simplex 
point with 𝑝௜௖  and start from 5. 
e. Otherwise, continue to step 11 
11. Shrink: 
a.   Replace every point except the best point (i.e. 𝑝௜  
where 𝑖 =  2, … , 𝑛 ) with 𝑝௜ = 𝑝ଵ + 𝜌(𝑝௜ − 𝑝ଵ). 
We follow the official MATLAB version and use 
𝜌 =  0.5. 
b. Start from step 5 
III. RESULTS 
A. Experimental Setup and Evaluation 
To determine the proficiency of our automated POPS 
algorithm, we compare it to gold-standard treatment plans 
created as part of routine clinical workflow. While these 
human-created treatment plans are not necessarily pareto 
optimal, they provide a benchmarking baseline in terms of 
clinical acceptability. Our comparisons utilize the SF score, 
which is described previously in Materials and Methods, to 
evaluate treatment plans both from our POPS algorithm and 
from human planners. Using our SF score, we can evaluate 
treatment plans on a scale between 0 and 1, where lower is 
better. Equations 1 and 2 are used to compute the SF score and 
are further explained in the Methods section.  
 The dataset used in our experiment consists of 21 prostate 
IMRT cases acquired from the Stanford Radiation Oncology 
Clinic (SROC). Scanner details, acquisition dates, and treating 
physician varied across cases. Gold-standard human-created 
treatment plans were created using a treatment planning system 
from Varian Medical Systems. As part of routine clinical 
workflow, various OARs (including the rectum, bladder, 
left/right femoral heads, and body) were contoured, along with 
the PTV. In order to mitigate the effect of beam angle selection 
on plan quality, we use a plan setting of 11 equally spaced 
photon beams (from 20° to 360° in increments of 32.7°). 
Similarly, a prescription dose of 76 Gy delivered over 40 
fractions, a bixel size of 5 𝑚𝑚, and a dose voxel size of 
3 × 3 × 3 𝑚𝑚ଷ were used as well. Our POPS algorithm 
additionally implements the open-source MatRad software 
package to perform inverse planning [4] which uses a pencil-
beam dose calculation algorithm and IPOPT[33].  
 As our POPS algorithm outputs pareto optimal plans, we 
expect it to produce treatment plans that perform at least as well 
as the human-created plans, within a small margin of error. In 
comparing SF score performance, we can compute the relative 
difference as the following: 
 
B. Comparison to Baseline and Initial Plans 
As mentioned, we perform comparisons between initial 
plans, dosimetrist generated plans (the gold-standard), and  
 
Figure 4. Visual comparison of initial, intermediate, and final treatment plans generated for an example patient using POPS. Dose 
conformity and organ sparing significantly improve from the initial plan after running POPS.  
 
Figure 3.  Boxplot visualization for 5D prostate IMRT cases, comparing initial plans to physician generated plans to POPS. 
generated plans.  
 
𝑅𝑒𝑙. 𝐷𝑖𝑓. (SF௉ை௉ௌ, SF௉௛௬௦)  
=  
SF௉ை௉ௌ  −  SF௉௛௬௦
1
2 (|SF௉ை௉ௌ| + |SF௉௛௬௦|)
 (6) 
POPS generated plans. These treatment plans are evaluated 
using the proposed SF score that allows for a quantitative 
evaluation of DVHs on a scale between 0 and 1, where lower is 
better. 
As demonstrated in Figure 3, our proposed POPS algorithm 
produces treatment plans that score better than the gold-
standard dosimetrist generated plans for all 21 patients. Paired 
t-test results additionally demonstrate significant improvement 
in favour of POPS generated plans over dosimetrist generated 
plans (𝑝 = 2.6 ⋅ 10ି଻) and initial plans (𝑝 = 4.0 ⋅ 10ିଵ ). 
Unsurprisingly, both POPS generated and dosimetrist 
generated treatment plans outperformed the initial plans in 
terms of SF scores. Figure 3 additionally demonstrates that 
POPS produced better scoring plans for each of the 21 cases, as 
the relative differences are all negative.  
A visualization of the differences in dose distribution 
between an example of a representative initial plan and the 
corresponding POPS generated plan is provided in Figure 4. We 
can visually appreciate the improvement to plan quality when 
comparing the final and initial plans. Moreover, we can 
visualize incremental improvements following iterations of the 
POPS algorithm. Upon arrival at the final plan, we observe 
substantial improvements to OAR sparing for all OARs as 
compared to the initial plan, as well as incremental 
improvement to sparing of the rectum when comparing the final 
plan to intermediate plans. Dose delivered to the PTV remains 
relatively homogenous throughout all iterations with dose 
conformity being noticeably improved in the final plan when 
comparing to the initial plan. 
Figure 5 provides visualizations of three example cases: 1) 
where the POPS provided a large improvement over the 
dosimetrist generated plan, 2) where POPS provided a moderate 
improvement, and 3) a case where the POPS and dosimetrist 
generated plans scored similarly. It is clear from all three cases 
that POPS generated plans perform better in sparing the rectum, 
which is assigned the highest priority in our SF score following 
the advice of consulted physicians.  
In the DVH for the large improvement case (row 2 column 1 
of Figure 5), we can appreciate substantial improvements to 
DVH curves for both the rectum (purple line) and bladder (blue 
line), along with similar performing DVH curves for the 
femoral heads and body. Clearly, the dosimetrist generated plan 
is not pareto optimal. In these scenarios, POPS produces more 
efficient plans than the dosimetrist, highlighting the importance 
of pareto optimality in treatment plan quality. The dose 
distribution (row 1 column 1 of Figure 5) for this large 
improvement case additionally demonstrates that PTV dose is 
highly conformal and the algorithm performs well in regards to 
OAR sparing. In the DVH for the moderate improvement case 
(row 2 column 2 of Figure 5), we observe significant 
improvements over the dosimetrist plan in regards to rectum 
sparing (purple line) at the expense of sparing to bladder (blue 
line). We suspect this trade-off occurs because the dosimetrist 
plan is close to pareto optimal, and POPS—with our current 
scoring function—assigns greater priority to the rectum than the 
bladder. Finally, in cases where POPS generated plans and 
dosimetrist generated plans score similarly, it is likely that the  
 
Figure 5. Visualization for three representative patients where POPS provided (1) large improvement, (2) moderate 
improvement, and (3) a similar score to physician generated plans. A visualization of the POPS generated dose distribution and 
DVH comparisons are provided for each case. 
dosimetrist generated plans are close to pareto optimal, and the 
dosimetrist’s assignment of OAR priority agrees with the OAR 
priorities listed in Table 1.  
Table 2 provides further quantitative comparison between 
dosimetrist generated plans and POPS generated plans. Here, 
five DVH control points were selected to provide an 
approximation of the DVH curve for each OAR. Dosage values 
are comparable between the two methods, demonstrating 
comparable OAR sparing. While POPS generally performs 
better for the rectum, femoral heads, and body, it performs 
slightly worse for the bladder. Overall, POPS produces pareto 
optimal plans that are highly comparable to dosimetrist 
generated plans with regards to clinical acceptability. 
IV. DISCUSSION 
This present study introduced a fully automated treatment 
planning algorithm, POPS. POPS combines projections using 
the bisection method and a gradient-free search to produce 
treatment plans that are both pareto optimal and clinically 
acceptable. To evaluate clinical acceptability, we compare 
POPS performance to manual planning by dosimetrists, the 
current gold-standard. Quantitative results for the 21 prostate 
IMRT cases in our dataset demonstrate that in every case, the 
POPS generated plan outperformed its corresponding 
dosimetrist generated plan in terms of SF score.  
A. POPS vs Other Approaches 
Automated treatment planning approaches have steadily 
grown in popularity due to their potential to drastically reduce 
active planning time [7], [8], [16], [20], [21], [23], [25], [28]. 
Following the iterative approach to treatment planning, human 
planners repeatedly adjust treatment planning parameters and 
perform inverse planning until a clinically acceptable solution 
is found. For IMRT cases, active planning time—planning time 
that directly utilizes a human planner’s decisions or actions—
for human planners has been reported to be on the order of 135 
minutes, with active planning time potentially increasing for 
more complex cases [25]. 
Endeavouring to reduce active planning time, a variety of 
automated approaches have been proposed, which can be 
generally categorized as knowledge-based planning, protocol- 
based planning, and MCO. As introduced earlier, knowledge-
based planning approaches typically leverage “black-box,” 
supervised machine learning approaches to predict components 
of dosimetrist generated plans (i.e. the dose distribution, DVH, 
etc.) [16]–[18]. On one hand, such approaches, in theory, have 
the potential to reproduce dosimetrists’ plans with high 
accuracy at exceedingly low computation times. On the other 
hand, such approaches, in practice, may suffer from poor 
generalization, poor interpretability, and limited effectiveness 
in outperforming their ground-truth dosimetrist generated plans 
[34]–[36]. 
Protocol-based methods attempt to mimic human planners 
performing iterative planning using carefully designed rules or 
trained reinforcement learning agents[7], [8], [20]–[23]. While 
practical, these methods are potentially limited by inter-planner 
variability and, like KBP, do not necessarily produce pareto 
optimal plans. 
MCO approaches, by contrast, attempt to produce pareto 
optimal solutions. Where a posteriori MCO (database MCO)  
 approaches attempt to generate the entire pareto front (or at 
least approximate the pareto front) [13], [24], [25], a priori 
MCO approaches select a pareto optimal plan based on 
physician-defined preferences for objective weights and dose 
constraints[6], [26], [28], [29]. Both types of MCO approaches 
produce pareto optimal plans but delegate the task of selecting 
clinically acceptable plans to the physician, either explicitly 
(i.e. in the case of a posteriori MCO) or implicitly through 
preferences (i.e. in the case of a priori MCO). 
While we do not have access to implementations of other 
MCO algorithms in the MatRad framework, we report their 
active planning times for rough comparison in Table 3. Our 
initial implementation of POPS requires no active planning 
Table 2. Comparison of DVH values for five uniformly selected control points (D(20%),  D(40%),  D(60%),  D(80%),  
D(98%)) between dosimetrist generated and POPS generated plans. Lower dosage values are better as they imply better OAR 
sparing. The lowest values for each OAR are also bolded. 
 
 OAR D(20%) (Gy) D(40%)  (Gy) D(60%) (Gy) D(80%) (Gy) D(98%) (Gy) 
Human Planner 
Rectum 53.9 (11.2) 32.8 (8.1) 21.1 (7.3) 10.0 (5.3) 3.1 (1.1) 
Bladder 36.6 (21.7) 15.2 (12.0) 7.0 (7.1) 3.9 (5.1) 2.0 (2.7) 
FH R 24.9 (4.9) 20.3 (4.4) 15.2 (4.2) 7.5 (4.4) 2.3 (1.3) 
FH L 23.0 (4.7) 17.9 (3.5) 13.7 (3.3) 7.1 (4.4) 2.2 (1.2) 
Body 3.5 (1.7) 0.6 (0.2) 0.2 (0.1) 0.1 (0.1) 0* 
POPS 
Rectum 49.1 (12.5) 29.4 (9.3) 18.4 (6.2) 10.1 (5.1) 4.0 (3.9) 
Bladder 42.8 (19.1) 19.9 (12.9) 10.0 (8.3) 5.1 (5.5) 2.6 (4.1) 
FH R 18.9 (4.2) 14.3 (4.2) 8.8 (4.1) 4.6 (2.9) 1.3 (1.3) 
FH L 20.0 (4.9) 16.0 (4.0) 10.4 (4.7) 5.1 (3.3) 1.1 (1.3) 
Body 3.6 (2.3) 0.2 (0.4) 0.1 (0.0) 0* 0* 
*Values were vanishingly small 
from human planners. Alternative a posteriori MCO 
approaches, for reference, require a human planner to select 
clinically acceptable plans from a database of pareto optimal 
solutions, resulting in a longer active planning time.  
One major benefit of having no active planning time is that 
many patients can be run in parallel, reducing the average time 
overall per patient and allowing for great scalability to servers 
or clusters. For our 5D prostate IMRT implementation, POPS 
utilizes 5 CPU threads. On our consumer-level desktop Ryzen 
2700x CPU (16 threads), up to 3 patients may be run 
simultaneously, which scales to potentially 25 patients on a 
Ryzen 3990x workstation and even more when factoring in 
servers or a gpu-based implementation. 
 Overall, our proposed POPS algorithm directly searches the 
pareto front for clinically acceptable treatment plans, as defined 
by a scoring function. We note that the particular scoring 
function can be interchanged, as desired, without affecting the 
functionality of the POPS algorithm. In contrast to previous 
categories of MCO approaches, POPS automates the selection 
process of a clinically acceptable plan. In practice, POPS 
provides a general framework that allows for the direct search 
of the pareto front. Based on results for 21 prostate IMRT cases, 
POPS generated plans score better than dosimetrist generated 
plans for all cases. Our comparisons use the clinical 
acceptability criteria proposed in previous work [32]. As 
treatment plan evaluation can be subjective, we certainly 
acknowledge that physicians can choose criteria that may be 
somewhat different from what we adopted in the present study. 
To that end, Table 1 can be modified as desired to better suit 
individual preferences without affecting the performance of the 
POPS algorithm. Similarly, we found our heuristics to work 
well for prostate IMRT planning, but they may also be 
modified, resulting in different hyperparameter values, to suit 
different anatomies or physician preferences. The POPS 
framework allows for the implementation of alternative scoring 
functions or clinical acceptability criteria. For a given scoring 
function and set of criteria, POPS produces treatment plans that 
satisfy the overall objective of this study: to produce treatment 
plans that are both pareto optimal and clinically acceptable in a 
fully automated fashion. 
B. Limitations and Potential Improvements to Speed 
Based on the reported computation times from Craft et al., 
MCO approaches that utilize approximations of the pareto front 
typically have computation times less than 10 minutes. Our 
current implementation, which uses the MatRad software 
package to perform inverse planning and does not yet utilize 
pareto front approximations, has computation times around an 
hour. We would like to clarify that the computation time 
differences are not the result of POPS. Rather, they can be 
attributed to two main factors: inverse planning software 
implementation differences and the PGEN approximation 
method (or equivalent pareto front approximation method).  
Each time POPS makes an adjustment to the search variables, 
the vast majority of time is spent in computing function 
evaluations (i.e. performing inverse planning), so the bottleneck 
to sequential throughput is inverse planning speed. We have 
implemented our POPS algorithm using the open source 
MatRad package so that our findings can be more easily verified 
by other studies, but implementation of POPS in alternative 
treatment planning software packages like Eclipse or 
RayStation or ConRad [3] will speed up computation 
accordingly. 
For our implementation, we make no additional assumptions 
or approximations in regards to dose constraints or objectives 
(beyond those made by the matRad software package), but 
recent works such as ConRad demonstrate dramatic 
improvements to inverse planning throughput if certain 
approximations are made [3]. Similarly, as reported by Craft et 
al. [24], [25], their implementation uses the PGEN 
approximation of the pareto front, requiring significantly fewer 
function evaluations to approximate the pareto front. We hope 
to apply both improvements to our POPS algorithm in the future 
and anticipate similarly large increases in speed as were 
observed in their works. 
V. CONCLUSION 
External beam radiation therapy is used for treatment of over 
60% of cancer patients. Within the radiation therapy workflow, 
the treatment planning process represents a bottleneck to high 
quality patient care, due to the time-consuming nature of the 
iterative planning process and inter-planner variability. 
Previous works in automated planning can be generally 
categorized as KBP, PBP, and MCO approaches, each having 
key limitations. Our proposed POPS algorithm attempts to 
address these limitations and provides a fully automated 
framework for performing pareto optimal treatment planning. 
Evaluation of treatment plan quality is an especially 
subjective and nuanced process. While we acknowledge that 
particular scoring of treatment plans may differ according to 
Table 3. Comparison of average computation times and active planning times required for each patient.  
 
Method Active Planning Time/Patient  
Human Planner* 135 min 
Approximated MCO (with RayStation implementation)* 12 min 
POPS (with MatRad implementation) 0 min 
* Based on reported average time from Craft et al. [25] 
 
planner expertise and preferences, we adopt a scoring function 
(SF) for the purpose of evaluating prostate IMRT plan quality 
in regards to clinical acceptability criteria previously proposed 
in literature[32]. Using this proposed SF score, we demonstrate 
that our proposed POPS algorithm produces plans that are both 
pareto optimal and clinically acceptable, as compared to 
manually generated plans. Our results indicate that POPS can 
substantially improve treatment planning workflow. 
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